Compare Exelixis Inc. Common Stock (EXEL) vs iShares International Treasury Bond ETF (IGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Exelixis Inc. Common Stock vs iShares International Treasury Bond ETF — how do they compare? Exelixis Inc. Common Stock trades at $59.86 (market cap $14.62B), while iShares International Treasury Bond ETF trades at $39.74 (market cap $1.30B). The key difference: Exelixis Inc. Common Stock is far larger — about 11.2× iShares International Treasury Bond ETF's market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, iShares International Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and iShares International Treasury Bond ETF for 92 Days on average.
| EXEL | IGOV | |
|---|---|---|
Market Cap | $14.62B | $1.30B |
Volume | 2,684,957 | 693,740 |
Sector | Health | Fixed Income |
52-Week High | $59.13 | $42.99 |
52-Week Low | $34.54 | $39.65 |
Typical Hold Time | 1 Days | 92 Days |
Enterprise Value | $13.95B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
IGOV trades at $39.73, up 0.08% on the day, with a bearish technical signal from moving averages but neutral oscillators. Key financial ratios such as P/E and P/S are not available in the provided data. Recent news highlights rising global bond yields, which may impact interest-rate-sensitive assets.
The outlook remains cautious due to bearish technicals and macroeconomic pressures from higher yields. Investment opportunities hinge on undisclosed fundamentals, while risks include market volatility and interest rate sensitivity. Investors should await clearer financial disclosures for a full assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →About iShares International Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →
